Literature DB >> 16971022

Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: role of microglia.

Xi-Jin Wang1, Zhi-Qiang Yan, Guo-Qiang Lu, Smith Stuart, Sheng-Di Chen.   

Abstract

Increasing evidence suggests the involvement of immune/inflammatory system in Parkinson's disease (PD). Many immune/inflammatory factors may synergistically participate in PD. In this study, we demonstrated that immunoglobulin G from the serum of 4/11 PD patients (PDIgG, 60microg/ml) and recombinant human C5a (0.1nM) synergistically induced selective dopaminergic neurodegeneration in rat mesencephalic neuron-glia cultures, while that PDIgG alone or C5a alone was minimally toxic or nontoxic. IgG from 17 disease controls and from 7 normal controls did not significantly induce dopaminergic neurotoxicity in the cultures even in the presence of C5a. Using mesencephalic neuron-enriched cultures, we found that the synergistic dopaminergic neurotoxicity was mediated by glia. The results from microglia-supplemented neuronal cultures, astroglia-supplemented neuronal cultures and neuron-astroglia cocultures indicated that microglia, not astroglia, played a pivotal role in the neurotoxicity. Through immunocytochemistry analysis and assay of proinflammatory factors, we observed that each of the four PDIgGs (60microg/ml) and C5a (0.1nM) synergistically induced microglia activation and production of superoxide and nitric oxide (NO) in neuron-glia cultures. Further investigations indicated that superoxide and NO were both responsible for the synergistic neurotoxicity. Finally, using F(ab')(2) fragments of PDIgG, we demonstrated that microglial Fc receptors may play an important role in the neurotoxicity. Our work provides new evidence for the involvement of the immune/inflammatory system in PD and helpful clues for studying the combined effect of antibody and complement on microglia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971022     DOI: 10.1016/j.neuint.2006.07.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  24 in total

1.  Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.

Authors:  Jinbo Cheng; Yajin Liao; Lei Xiao; Rong Wu; Siqi Zhao; Hong Chen; Baidong Hou; Xia Zhang; Chengyu Liang; Yun Xu; Zengqiang Yuan
Journal:  Cell Death Differ       Date:  2016-11-04       Impact factor: 15.828

2.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

3.  Genome-wide association study confirms extant PD risk loci among the Dutch.

Authors:  Javier Simón-Sánchez; Jacobus J van Hilten; Bart van de Warrenburg; Bart Post; Henk W Berendse; Sampath Arepalli; Dena G Hernandez; Rob M A de Bie; Daan Velseboer; Hans Scheffer; Bas Bloem; Karin D van Dijk; Fernando Rivadeneira; Albert Hofman; André G Uitterlinden; Patrizia Rizzu; Zoltan Bochdanovits; Andrew B Singleton; Peter Heutink
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

4.  Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (I CRAC) but not Ca2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells.

Authors:  Andreas Beck; Reinhold Penner; Andrea Fleig
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

5.  Microglia in the aging brain: relevance to neurodegeneration.

Authors:  Xiao-Guang Luo; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mol Neurodegener       Date:  2010-03-24       Impact factor: 14.195

6.  Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease.

Authors:  Xiao-Guang Luo; Ji-Juan Zhang; Chao-Dong Zhang; Rong Liu; Lan Zheng; Xi-Jin Wang; Sheng-Di Chen; Jian-Qing Ding
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

Review 7.  The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review.

Authors:  Zeinab Ashaari; Mousa-Al-Reza Hadjzadeh; Gholamreza Hassanzadeh; Tahereh Alizamir; Behpour Yousefi; Zakieh Keshavarzi; Tahmineh Mokhtari
Journal:  J Mol Neurosci       Date:  2018-08-06       Impact factor: 3.444

Review 8.  CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease.

Authors:  Xi-Jin Wang; Min Ye; Yu-Hong Zhang; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2007-05-18       Impact factor: 4.147

Review 9.  Innate and adaptive immunity for the pathobiology of Parkinson's disease.

Authors:  David K Stone; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

10.  IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fcα/μ Receptor.

Authors:  Jonathan R Weinstein; Yi Quan; Josiah F Hanson; Lucrezia Colonna; Michael Iorga; Shin-ichiro Honda; Kazuko Shibuya; Akira Shibuya; Keith B Elkon; Thomas Möller
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.